TACKLING INFECTIOUS DISEASES
Aspen is committed to playing a meaningful role in tackling infectious diseases. Aspen is an established leader in the provision of generic ARVs to HIV/AIDS patients throughout Africa, covering some 300 000 lives. Aspen is set to add to its already extensive ARV product offering with a range of new products currently in development. The Group is pursuing new initiatives which will allow it to offer treatment for tuberculosis as well as multi-drug resistant tuberculosis. Each year more than eight million new tuberculosis cases are diagnosed globally.
Aspen Annual Report 2006